论文部分内容阅读
肿瘤细胞对阿糖胞苷耐药性与脱氧胞苷激酶刘西平综述朱定尔审校耐药机制的研究是近来肿瘤临床和基础研究中的热点。阿糖胞苷（Ａｒａ－Ｃ）是一种最有效的诱导急性非淋巴细胞白血病缓解的药物，结合其它抗癌药物治疗，阿糖胞苷可使７０％的患者获得完全缓解［１］。然而由...
The study of cytarabine resistance and deoxycytidine kinase Liu Xiping in tumor cells is a hot topic in the recent clinical and basic research of oncology. Cytosine arabinoside (Ara-C) is one of the most effective drugs to induce acute non-lymphocytic leukemia. In combination with other anti-cancer drugs, cytarabine can achieve complete remission in 70% of patients [1]. However, by...